Brief Summary
Provide patients with serious AdV infection or disease access to treatment with BCV.
Brief Title
Expanded Access Protocol to Provide Brincidofovir for the Treatment of Serious Adenovirus Infection or Disease
Conditions
Adenovirus
Eligibility Criteria
Inclusion Criteria:
* Confirmed serious AdV infection based on clinical symptoms and laboratory testing showing AdV in the blood or other bodily fluids
* Able to swallow medication, either tablet or liquid
Exclusion Criteria:
* Previous dosing with Brincidofovir
* If female, not pregnant or trying to become pregnant
* Confirmed serious AdV infection based on clinical symptoms and laboratory testing showing AdV in the blood or other bodily fluids
* Able to swallow medication, either tablet or liquid
Exclusion Criteria:
* Previous dosing with Brincidofovir
* If female, not pregnant or trying to become pregnant
Inclusion Criteria
Inclusion Criteria:
* Confirmed serious AdV infection based on clinical symptoms and laboratory testing showing AdV in the blood or other bodily fluids
* Able to swallow medication, either tablet or liquid
* Confirmed serious AdV infection based on clinical symptoms and laboratory testing showing AdV in the blood or other bodily fluids
* Able to swallow medication, either tablet or liquid
Gender
All
Gender Based
false
Keywords
Adenovirus Brincidofovir
Last Update Post Date
Last Update Post Date Type
Actual
Last Update Submit Date
Minimum Age
2 Months
NCT Id
NCT02596997
Org Class
Industry
Org Full Name
Chimerix
Org Study Id
CMX001-351
Overall Status
No longer available
Official Title
An Intermediate-size, Expanded Access Protocol to Provide Brincidofovir for the Treatment of Serious Adenovirus Infection or Disease
Status Verified Date
First Post Date
First Post Date Type
Estimated
First Submit Date
First Submit QC Date
Std Ages
Child
Adult
Older Adult
Maximum Age Number (converted to Years and rounded down)
999
Minimum Age Number (converted to Years and rounded down)
0
Investigators
Investigator Type
Principal Investigator
Investigator Name
Deepa Manwani
Investigator Email
dmanwani@montefiore.org
Investigator Phone
718-741-2342
Categories Mesh Debug
COVID-19 --- VIRUS DISEASES
Hepatitis --- VIRUS DISEASES
Infectious Disease --- VIRUS DISEASES
COVID-19 --- INFECTIONS
Infectious Disease --- INFECTIONS
MeSH Terms
ADENOVIRIDAE INFECTIONS
DNA VIRUS INFECTIONS
VIRUS DISEASES
INFECTIONS
BRINCIDOFOVIR